American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington, D.C.

Book  Google Scholar 

Baird G, Charman T, Pickles A, Chandler S, Loucas T, Meldrum D, Carcani-Rathwell I, Serkana D, Simonoff E (2008) Regression, developmental trajectory and associated problems in disorders in the autism spectrum: the SNAP study. J Autism Dev Disord 38(10):1827–1836. https://doi.org/10.1007/s10803-008-0571-9

Article  PubMed  Google Scholar 

Barone R, Alaimo S, Messina M, Pulvirenti A, Bastin J, Ferro A, Frye RE, Rizzo R, MIMIC-Autism Group (2018) A subset of patients with autism spectrum disorders show a distinctive metabolic profile by dried blood spot analyses. Front Psychiatry 9. https://doi.org/10.3389/fpsyt.2018.00636

Bugajska J, Berska J, Wojtyto T, Bik-Multanowski M, Sztefko K (2017) The amino acid profile in blood plasma of young boys with autism. Psychiatr Pol 51(2):359–368. https://doi.org/10.12740/pp/65046

Article  PubMed  Google Scholar 

Chiarotti F, Venerosi A (2020) Epidemiology of autism spectrum disorders: a review of worldwide prevalence estimates since 2014. Brain Sci 10(5):274. https://doi.org/10.3390/brainsci10050274

Article  PubMed  PubMed Central  Google Scholar 

Chlebowski C, Green JA, Barton ML, Fein D (2010) Using the childhood autism rating scale to diagnose autism spectrum disorders. J Autism Dev Disord 40(7):787–799. https://doi.org/10.1007/s10803-009-0926-x

Article  PubMed  PubMed Central  Google Scholar 

Desai A, Sequeira JM, Quadros EV (2016) The metabolic basis for developmental disorders due to defective folate transport. Biochimie 126:31–42. https://doi.org/10.1016/j.biochi.2016.02.012

Article  CAS  PubMed  Google Scholar 

Domenici MR, Ferrante A, Martire A, Chiodi V, Pepponi R, Tebano MT, Popoli P (2019) Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders. Pharmacol Research: Official J Italian Pharmacol Soc 147(104338):104338. https://doi.org/10.1016/j.phrs.2019.104338

Article  CAS  Google Scholar 

Essa MM, Braidy N, Vijayan KR, Subash S, Guillemin GJ (2013) Excitotoxicity in the pathogenesis of autism. Neurotox Res 23(4):393–400. https://doi.org/10.1007/s12640-012-9354-3

Article  CAS  PubMed  Google Scholar 

Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ (2004) Relative carnitine deficiency in autism. J Autism Dev Disord 34(6):615–623. https://doi.org/10.1007/s10803-004-5283-1

Article  PubMed  Google Scholar 

Frye RE, Melnyk S, MacFabe DF (2013) Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Translational Psychiatry 3(1):e220–e220. https://doi.org/10.1038/tp.2012.143

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frye RE, Vassall S, Kaur G, Lewis C, Karim M, Rossignol D (2019) Emerging biomarkers in autism spectrum disorder: a systematic review. Annals Translational Med 7(23):792–792. https://doi.org/10.21037/atm.2019.11.53

Article  CAS  Google Scholar 

Geier DA, Kern JK, Davis G, King PG, Adams JB, Young JL, Geier MR (2011) A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med Sci Monitor: Int Med J Experimental Clin Res 17(6):PI15–PI23. https://doi.org/10.12659/msm.881792

Article  Google Scholar 

Glinton KE, Elsea SH (2019) Untargeted metabolomics for autism spectrum disorders: current status and future directions. Front Psychiatry 10. https://doi.org/10.3389/fpsyt.2019.00647

Kelly RS, Boulin A, Laranjo N, Lee-Sarwar K, Chu SH, Yadama AP, Carey V, Litonjua AA, Lasky-Su J, Weiss ST (2019) Metabolomics and communication skills development in children; evidence from the ages and stages questionnaire. Metabolites 9(3):42. https://doi.org/10.3390/metabo9030042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khachadourian V, Mahjani B, Sandin S, Kolevzon A, Buxbaum JD, Reichenberg A, Janecka M (2023) Comorbidities in autism spectrum disorder and their etiologies. Translational Psychiatry 13(1). https://doi.org/10.1038/s41398-023-02374-w

Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M, Takano Y, Iwashiro N, Natsubori T, Aoki Y, Kano Y, Kasai K (2013) Altered metabolites in the plasma of autism spectrum disorder: A capillary electrophoresis time-of-flight mass spectroscopy study. PLoS ONE 8(9):e73814. https://doi.org/10.1371/journal.pone.0073814

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lombard J (1998) Autism: a mitochondrial disorder? Med Hypotheses 50(6):497–500. https://doi.org/10.1016/s0306-9877(98)90270-5

Article  CAS  PubMed  Google Scholar 

Lv Q-Q, You C, Zou X-B, Deng H-Z (2018) Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children. Psychiatry Res 267:277–280. https://doi.org/10.1016/j.psychres.2018.06.027

Article  CAS  PubMed  Google Scholar 

Masino SA, Kawamura M Jr, Plotkin LM, Svedova J, DiMario FJ Jr, Eigsti I-M (2011) The relationship between the neuromodulator adenosine and behavioral symptoms of autism. Neurosci Lett 500(1):1–5. https://doi.org/10.1016/j.neulet.2011.06.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maynard TM, Manzini MC (2017) Balancing act: maintaining amino acid levels in the autistic brain. Neuron 93(3):476–479. https://doi.org/10.1016/j.neuron.2017.01.015

Article  CAS  PubMed  Google Scholar 

McPartland JC, Reichow B, Volkmar FR (2012) Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 51(4):368–383. https://doi.org/10.1016/j.jaac.2012.01.007

Article  PubMed  PubMed Central  Google Scholar 

Needham BD, Adame MD, Serena G, Rose DR, Preston GM, Conrad MC, Campbell AS, Donabedian DH, Fasano A, Ashwood P, Mazmanian SK (2021) Plasma and fecal metabolite profiles in autism spectrum disorder. Biol Psychiatry 89(5):451–462. https://doi.org/10.1016/j.biopsych.2020.09.025

Article  CAS  PubMed  Google Scholar 

Rangel-Huerta OD, Gomez-Fernández A, de la Torre-Aguilar MJ, Gil A, Perez-Navero JL, Flores-Rojas K, Martín-Borreguero P, Gil-Campos M (2019) Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case–control study. Metabolomics: Official J Metabolomic Soc 15(7). https://doi.org/10.1007/s11306-019-1562-x

Robins DL, Casagrande K, Barton M, Chen C-MA, Dumont-Mathieu T, Fein D (2014) Validation of the modified checklist for autism in toddlers, revised with follow-up (M-CHAT-R/F). Pediatrics 133(1):37–45. https://doi.org/10.1542/peds.2013-1813

Article  PubMed  PubMed Central  Google Scholar 

Roopesh BN (2022) Advanced scoring and interpretation of vineland social maturity scale: procedure to obtain ’impairment adjusted social quotient. Indian J Mental Health 9(1):13–24. https://doi.org/10.30877/ijmh.9.1.2022.13-24

Article  Google Scholar 

Smith AM, King JJ, West PR, Ludwig MA, Donley ELR, Burrier RE, Amaral DG (2019) Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder. Biol Psychiatry 85(4):345–354. https://doi.org/10.1016/j.biopsych.2018.08.016

Article  CAS  PubMed  Google Scholar 

Thurm A, Manwaring SS, Luckenbaugh DA, Lord C, Swedo SE (2014) Patterns of skill attainment and loss in young children with autism. Dev Psychopathol 26(1):203–214. https://doi.org/10.1017/s0954579413000874

Article  PubMed  Google Scholar 

Vats P, Juneja M, Mishra D (2018) Diagnostic accuracy of international epidemiology network (INCLEN) diagnostic tool for autism spectrum disorder (INDT-ASD) in comparison with diagnostic and statistical manual of mental disorders-5 (DSM-5). Indian Pediatr 55(6). https://pubmed.ncbi.nlm.nih.gov/29978815/

Wang H, Liang S, Wang M, Gao J, Sun C, Wang J, Xia W, Wu S, Sumner SJ, Zhang F, Sun C, Wu L (2016) Potential serum biomarkers from a metabolomics study of autism. J Psychiatry Neuroscience: JPN 41(1):27–37. https://doi.org/10.1503/jpn.140009

Article  Google Scholar 

West PR, Amaral DG, Bais P, Smith AM, Egnash LA, Ross ME, Palmer JA, Fontaine BR, Conard KR, Corbett BA, Cezar GG, Donley ELR, Burrier RE (2014) Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children. PLoS ONE 9(11):e112445. https://doi.org/10.1371/journal.pone.0112445

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaki MM, Abdel-Al H, Al-Sawi M (2017) Assessment of plasma amino acid profile in autism using cation-exchange chromatography with postcolumn derivatization by ninhydrin. Turk J Med Sci 47(1):260–267. https://doi.org/10.3906/sag-1506-105

Article  CAS  PubMed  Google Scholar 

Zwaigenb